Eupraxia Pharmaceuticals Inc(EPRX-T)TSX
Today's Change
Real-Time Last Update
Pre Market Change
Pre Market Last Update
Volume
Eupraxia Pharmaceuticals Inc
201-2067 Cadboro Bay RoadVictoria BC V8R 5G4 CAN
P: 250-590-3968
https://www.eupraxiapharma.com
Profile
Eupraxia Pharmaceuticals Inc is a clinical-stage biotechnology company focused on the development of locally delivered, extended-release alternatives to existing pharmaceuticals. Its product EP-104 is used for the treatment of osteoarthritis and eosinophilic esophagitis symptoms. The company leverages its proprietary Diffusphere technology to optimize drug delivery for applications with significant unmet medical needs.
Key Executives
| Name | Title |
|---|---|
| Paul Brennan | Other Executive Officer |
| Bruce G. Cousins | CFO/President |
| Mark Kowalski | Chief Medical Officer |
| James A. Helliwell | CEO/Co-Founder/Director |
| Amanda Malone | Chief Scientific Officer/COO |